Skip to content
lifestyle.brickvest.com
Animals
Auto
Beauty & Style
Business News
Entertainment
Food
Health
Home & Family
Podcasts
Tech
Travel
Author:
Capricor Therapeutics
Capricor Therapeutics to Present at Upcoming Investor Conferences
June 8, 2026
Capricor Therapeutics Announces Late-Breaking Presentation of HOPE-3 Phase 3 Results at the American Academy of Neurology 2026 Annual Meeting
May 23, 2026
Capricor Therapeutics Reports First Quarter 2026 Financial Results and Provides Corporate Update
May 21, 2026
Capricor Therapeutics Announces Late-Breaking HOPE-3 Data at the 2026 MDA Conference Demonstrating Significant Functional Benefits of Deramiocel for Duchenne Muscular Dystrophy
May 16, 2026
Capricor Therapeutics Announces Establishment of New PDUFA Date for Deramiocel BLA
May 16, 2026
Capricor Therapeutics Provides Regulatory Update on Deramiocel BLA Following FDA Review of HOPE-3 Topline Data
January 20, 2026